Literature DB >> 19095631

Prostanoids in health and disease.

Emer M Smyth1, Tilo Grosser, Miao Wang, Ying Yu, Garret A FitzGerald.   

Abstract

The prostanoids are a family of lipid mediators generated by the action of cyclooxygenase on a 20-carbon unsaturated fatty acid, arachidonic acid. Prostanoids are generated widely in response to diverse stimuli and, acting in a paracrine or autocrine manner, play important roles in normal physiology and disease. This review summarizes the current knowledge on prostanoid generation and the roles of individual mediators, their biosynthetic pathways, and their receptors in health and disease.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19095631      PMCID: PMC2674745          DOI: 10.1194/jlr.R800094-JLR200

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  48 in total

Review 1.  Mechanisms of platelet activation: thromboxane A2 as an amplifying signal for other agonists.

Authors:  G A FitzGerald
Journal:  Am J Cardiol       Date:  1991-09-03       Impact factor: 2.778

2.  Cyclooxygenases, thromboxane, and atherosclerosis: plaque destabilization by cyclooxygenase-2 inhibition combined with thromboxane receptor antagonism.

Authors:  Karine M Egan; Miao Wang; Susanne Fries; Margaret B Lucitt; Alicia M Zukas; Ellen Puré; John A Lawson; Garret A FitzGerald
Journal:  Circulation       Date:  2005-01-17       Impact factor: 29.690

Review 3.  Adverse effects of cyclooxygenase 2 inhibitors on renal and arrhythmia events: meta-analysis of randomized trials.

Authors:  Jingjing Zhang; Eric L Ding; Yiqing Song
Journal:  JAMA       Date:  2006-09-12       Impact factor: 56.272

4.  COX-2-derived prostacyclin confers atheroprotection on female mice.

Authors:  Karine M Egan; John A Lawson; Susanne Fries; Beverley Koller; Daniel J Rader; Emer M Smyth; Garret A Fitzgerald
Journal:  Science       Date:  2004-11-18       Impact factor: 47.728

5.  Microsomal prostaglandin E synthase-1 is the central switch during immune-induced pyresis.

Authors:  David Engblom; Sipra Saha; Linda Engström; Marie Westman; Laurent P Audoly; Per-Johan Jakobsson; Anders Blomqvist
Journal:  Nat Neurosci       Date:  2003-10-19       Impact factor: 24.884

6.  Dimerization of the human receptors for prostacyclin and thromboxane facilitates thromboxane receptor-mediated cAMP generation.

Authors:  Stephen J Wilson; Aoife M Roche; Ekaterina Kostetskaia; Emer M Smyth
Journal:  J Biol Chem       Date:  2004-10-07       Impact factor: 5.157

Review 7.  The isoprostanes: unique products of arachidonic acid oxidation-a review.

Authors:  Samuel S Fam; Jason D Morrow
Journal:  Curr Med Chem       Date:  2003-09       Impact factor: 4.530

8.  Roles of thromboxane A(2) and prostacyclin in the development of atherosclerosis in apoE-deficient mice.

Authors:  Takuya Kobayashi; Yoshio Tahara; Mayumi Matsumoto; Masako Iguchi; Hideto Sano; Toshinori Murayama; Hidenori Arai; Hiroji Oida; Takami Yurugi-Kobayashi; Jun K Yamashita; Hiroyuki Katagiri; Masataka Majima; Masayuki Yokode; Toru Kita; Shuh Narumiya
Journal:  J Clin Invest       Date:  2004-09       Impact factor: 14.808

Review 9.  Cyclooxygenase-2 and inflammation in atherosclerosis.

Authors:  MacRae F Linton; Sergio Fazio
Journal:  Curr Opin Pharmacol       Date:  2004-04       Impact factor: 5.547

Review 10.  Pharmacology and signaling of prostaglandin receptors: multiple roles in inflammation and immune modulation.

Authors:  Aaron N Hata; Richard M Breyer
Journal:  Pharmacol Ther       Date:  2004-08       Impact factor: 12.310

View more
  167 in total

1.  Role of prostaglandins in fibroblast activation and fibrosis.

Authors:  Richard Stratton; Xu Shiwen
Journal:  J Cell Commun Signal       Date:  2010-03-26       Impact factor: 5.782

Review 2.  The electrophile responsive proteome: integrating proteomics and lipidomics with cellular function.

Authors:  Ashlee N Higdon; Aimee Landar; Stephen Barnes; Victor M Darley-Usmar
Journal:  Antioxid Redox Signal       Date:  2012-04-18       Impact factor: 8.401

3.  Cyclooxygenase-2 deficiency leads to intestinal barrier dysfunction and increased mortality during polymicrobial sepsis.

Authors:  Laura E Fredenburgh; Margarita M Suárez Velandia; Jun Ma; Torsten Olszak; Manuela Cernadas; Joshua A Englert; Su Wol Chung; Xiaoli Liu; Cynthia Begay; Robert F Padera; Richard S Blumberg; Stephen R Walsh; Rebecca M Baron; Mark A Perrella
Journal:  J Immunol       Date:  2011-10-03       Impact factor: 5.422

4.  Serum concentrations of cyclooxygenase-2 in patients with systemic sclerosis: association with lower frequency of pulmonary fibrosis.

Authors:  Iman H Bassyouni; Roba M Talaat; Tarek A Salem
Journal:  J Clin Immunol       Date:  2011-10-07       Impact factor: 8.317

5.  Seeing the future of bioactive lipid drug targets.

Authors:  Jilly F Evans; John H Hutchinson
Journal:  Nat Chem Biol       Date:  2010-07       Impact factor: 15.040

6.  Roles of affinity and lipophilicity in the slow kinetics of prostanoid receptor antagonists on isolated smooth muscle preparations.

Authors:  R L Jones; D F Woodward; J W Wang; R L Clark
Journal:  Br J Pharmacol       Date:  2011-02       Impact factor: 8.739

7.  Aspirin as a Potential Geroprotector: Experimental Data and Clinical Evidence.

Authors:  Oleh Lushchak; Veronika Piskovatska; Olha Strilbytska; Iryna Kindrat; Nadya Stefanyshyn; Alexander Koliada; Volodymyr Bubalo; Kenneth B Storey; Alexander Vaiserman
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 8.  Understanding inflammatory pain: ion channels contributing to acute and chronic nociception.

Authors:  John E Linley; Kirstin Rose; Lezanne Ooi; Nikita Gamper
Journal:  Pflugers Arch       Date:  2010-02-17       Impact factor: 3.657

9.  Impact of a Standard Rodent Chow Diet on Tissue n-6 Fatty Acids, Δ9-Desaturation Index, and Plasmalogen Mass in Rats Fed for One Year.

Authors:  F Pédrono; N Boulier-Monthéan; D Catheline; P Legrand
Journal:  Lipids       Date:  2015-09-19       Impact factor: 1.880

10.  Quantitation of celecoxib and four of its metabolites in rat blood by UPLC-MS/MS clarifies their blood distribution patterns and provides more accurate pharmacokinetics profiles.

Authors:  Yong Ma; Song Gao; Ming Hu
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2015-07-19       Impact factor: 3.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.